SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-151713
Filing Date
2021-05-05
Accepted
2021-05-05 16:10:00
Documents
4
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d305015ddef14a.htm DEF 14A 399324
2 GRAPHIC g305015g02r58.jpg GRAPHIC 49967
3 GRAPHIC g305015g05e64.jpg GRAPHIC 35557
4 GRAPHIC g305015g27n06.jpg GRAPHIC 25065
  Complete submission text file 0001193125-21-151713.txt   538673
Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39401 | Film No.: 21893320
SIC: 2836 Biological Products, (No Diagnostic Substances)